OBSERVATIONAL STUDY OF RESOURCE USE AND COST OF ALZHEIMER'S DISEASE IN EUROPE (GERAS) - 18-MONTH RESULTS FROM THE FRENCH COHORT
Author(s)
Rapp T1, Vellas B2, Andrieu S3, Chartier F4, Baraille L4, Belger M5
1University of Paris Descartes, Paris, France, 2University Hospital of Toulouse, Toulouse, France, 3Toulouse University Hospital, Toulouse, France, 4Eli and Lilly, Neuilly-sur-Seine Cedex, France, 5Eli Lilly and Company Ltd, Windlesham, UK
OBJECTIVES: To describe 18-month health care resource use and costs associated with Alzheimer’s disease (AD) for patients and caregivers in France, stratified by AD severity at baseline. METHODS: RESULTS: CONCLUSIONS: This longitudinal study showed that costs increase with AD severity. Informal care cost represents the largest part of total societal cost at each intermediate time point.
Conference/Value in Health Info
2015-11, ISPOR Europe 2015, Milan, Italy
Value in Health, Vol. 18, No. 7 (November 2015)
Code
PMH18
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Mental Health